<- Back to digest

JAAOS - 2026-10-01 - Journal Article

Psychiatric and Somatic Sequelae After Total Hip Arthroplasty in Patients With Major Depressive Disorder: A Propensity-Matched Analysis.

Wahid M, Zaidi Z, Nasser E, Meza C, Chen AF

retrospective cohortLOE IIIn = 6,824 (3,412 matched pairs from 150,504 total patients)90 days and 1 year

Topics

arthroplasty
PMID: 41429013DOI: 10.5435/JAAOS-D-25-00751View on PubMed ->

Key Takeaway

MDD independently increases 1-year post-THA suicide risk 6.71-fold and all-cause mortality 1.96-fold compared to propensity-matched controls without psychiatric comorbidity.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This study asked whether isolated MDD independently predicts new psychiatric and somatic morbidity after primary THA using a multi-institutional database (2015–2024) with propensity score matching. MDD patients demonstrated dramatically elevated odds of new-onset GAD (OR 16.53 at 1 year), dementia (OR 9.27), PTSD (OR 7.33), and suicide (OR 6.71) compared to matched controls. Somatic risks including mortality (OR 1.96), chest pain (OR 1.25), and ED revisits (OR 1.27) were also significantly elevated at 1 year.

Key Limitation

Database diagnosis codes cannot distinguish new-onset psychiatric conditions from pre-existing diagnoses newly documented in the perioperative encounter, potentially inflating incidence estimates for conditions like dementia and schizophrenia.

Original Abstract

INTRODUCTION

This study evaluated whether major depressive disorder (MDD), a common comorbidity affecting outcomes after total hip arthroplasty (THA), is independently associated with new-onset psychiatric and somatic morbidity.

METHODS

Adults undergoing primary THA (2015-2024) were identified from a multi-institutional database, excluding patients with prior hip pathology or psychiatric diagnoses other than MDD. Propensity score-matched cohorts were compared at 90 days and 1 year using odds ratios (OR) with 95% confidence intervals (CI).

RESULTS

After exclusions, 5,864 patients with MDD and 144,640 control subjects were identified, yielding 3,412 matched pairs. P < 0.001 unless otherwise noted. MDD was associated with significantly higher odds of new-onset psychiatric disorders at 90 days and 1 year, including generalized anxiety disorder (OR 90d , 22.48: 95% CI, 14.6-34.5; OR 1yr , 16.53: 95% CI, 12.0-22.8), adjustment disorder (OR 90d , 5.81: 95% CI, 3.9-8.6; OR 1yr , 5.40: 95% CI, 3.9-7.4), posttraumatic stress disorder (OR 90d , 4.14: 95% CI, 2.8-6.1; OR 1yr , 7.33: 95%, CI 5.4-9.9), schizophrenia (OR 90d , 2.21: 95% CI, 1.1-4.6: P = 0.03; OR 1yr , 2.22: 95% CI, 1.3-3.8: P = 0.002), alcohol use disorder (OR 90d , 3.73: 95% CI, 2.6-5.4; OR 1yr , 2.61: 95% CI, 1.9-3.6), opioid use disorder (OR 90d , 2.31: 95% CI, 1.2-4.3: P = 0.02; OR 1yr , 2.69: 95% CI, 1.7-4.2), dementia (OR 90d , 12.24: 95% CI, 8.2-18.3; OR 1yr , 9.27: 95% CI, 6.6-13.0), and suicide (OR 1yr , 6.71: 95% CI, 3.7-12.0). Somatic risks included mortality (OR 90d , 2.26: 95% CI, 1.1-4.5: P = 0.02; OR 1yr , 1.96: 95% CI, 1.4-2.7), chest pain (OR 90d , 1.74: 95% CI, 1.3-2.3; OR 1yr , 1.25: 95% CI, 1.1-1.5, P = 0.007), shortness of breath (OR 90d , 1.28: 95% CI, 1.0-1.7: P = 0.0498; OR 1yr , 1.28: 95% CI, 1.1-1.5, P = 0.002), dizziness (OR 1yr , 1.49: 95% CI, 1.2-1.8), and postoperative emergency department visits (OR 1yr , 1.27: 95% CI, 1.1-1.5).

CONCLUSION

In patients with isolated MDD, the condition independently increased psychiatric, cognitive, somatic, and mortality risks after THA.